ArticleActa neuropathologica communications2024

Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection.

Anne Rombaut et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.